Clinical trials recruiting in Poulsbo, Washington
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 1 1Phase 2 2Phase 3 4Not applicable 1
Conditions recruiting in Poulsbo, Washington
Recruiting trials in Poulsbo, Washington
- A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
- Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
- Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Common questions
How many clinical trials are recruiting in Poulsbo, Washington?
7 recruiting trials have at least one study site in Poulsbo, Washington.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.